Koers Medeon Biodesign Inc Taipei Exchange
Aandelen
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
||
- | - |
Omzet 2022 | 298 mln. 9,19 mln. 0 8,46 mln. | Omzet 2023 | 196 mln. 6,05 mln. 0 5,57 mln. | Marktkapitalisatie | 4,29 mld. 132 mln. 0 122 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -434 mln. -13,37 mln. - -12,31 mln. | Nettowinst (verlies) 2023 | -1,2 mld. -37,12 mln. - -34,18 mln. | EV/omzet 2022 | 12,5 x |
Nettoliquiditeiten 2022 | 1,35 mld. 41,54 mln. 0 38,25 mln. | Nettoliquiditeiten 2023 | 1,96 mld. 60,23 mln. 0 55,46 mln. | EV/omzet 2023 | 11,9 x |
K/w-verhouding 2022 |
-11,7
x | K/w-verhouding 2023 |
-3,56
x | Werknemers | - |
Dividendrendement 2022 |
0,86% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 47,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 22-12-12 |
Ching Yi Chen
DFI | Director of Finance/CFO | - | - |
Greta Chang
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 22-12-12 |
Chih Lung Shen
BRD | Director/Board Member | 59 | 20-04-15 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 14-01-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,01% | 217 mld. | |
+11,01% | 190 mld. | |
+19,20% | 143 mld. | |
+30,79% | 111 mld. | |
+1,48% | 64,59 mld. | |
+13,95% | 52,36 mld. | |
-0,16% | 48,45 mld. | |
-6,20% | 38,03 mld. | |
+0,91% | 35,61 mld. |
- Beurs
- Aandelen
- Koers 6499
- Koers